Skip to main content

Advertisement

Log in

The efficacy of autologous serum eye drops for severe dry eye syndrome: a randomized double-blind crossover study

  • Cornea
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Background

To evaluate the efficacy of autologous serum (AS) eye drops for the symptomatic relief of severe dry eye syndrome (DES), as compared to conventional preservative-free artificial tears (PFAT).

Methods

This prospective double-blind randomized crossover study used the Ocular Surface Disease Index (OSDI), tear film break-up time (TBUT), Schirmer’s Test, and OXFORD Scale at baseline and after each of two 1-month treatment periods to measure the effect of 20 % diluted AS eye drops vs. PFAT in 20 consecutive severe DES patients that were refractory to conventional treatment.

Results

The study included 20 (18 female and two male) severe DES patients (40 eyes). Significantly higher TBUT (P < 0.001, Wilcoxon signed-rank test) and a greater decrease in OSDI score (55.18 % decrease in the AS treatment group vs. 19.50 % decrease in the PFAT treatment group) (P < 0.001, Student’s paired samples t-test) were observed in the AS treatment group after 1 month of treatment. There wasn’t a significant difference in Schirmer’s test and OXFORD conjunctival and corneal vital dying grading scores between the two treatment groups after 1 month of treatment (P > 0.05 [Mann–Whitney U test]).

Conclusions

AS eye drops were more effective than conventional eye drops for improving tear film stability and subjective comfort in patients with severe DES.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Yoon KC, Im SK, Park YG, Jung YD, Yang SY, Choi J (2006) Application of umbilical cord serum eyedrops for the treatment of dry eye syndrome. Cornea 25:268–272

    Article  PubMed  Google Scholar 

  2. Bradley JC, Bradley RH, McCartney DL, Mannis MJ (2008) Serum growth factor analysis in dry eye syndrome. Clin Exp Ophthalmol 36:717–720

    Article  Google Scholar 

  3. Poon AC, Geerling G, Dart JK, Fraenkel GE, Daniels JT (2001) Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies. Br J Ophthalmol 85:1188–1197

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  4. Ohashi Y, Ishida R, Kojima T, Goto E, Matsumoto Y, Watanabe K, Ishida N, Nakata K, Takeuchi T, Tsubota K (2003) Abnormal protein profiles in tears with dry eye syndrome. Am J Ophthalmol 136:291–299

    Article  PubMed  CAS  Google Scholar 

  5. Research in dry eye: report of the Research Subcommittee of the International Dry Eye WorkShop (2007) Ocul Surf 5:179–193

    Article  Google Scholar 

  6. Noble BA, Loh RS, MacLennan S, Pesudovs K, Reynolds A, Bridges LR, Burr J, Stewart O, Quereshi S (2004) Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease. Br J Ophthalmol 88:647–652

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  7. Lee GA, Chen SX (2008) Autologous serum in the management of recalcitrant dry eye syndrome. Clin Exp Ophthalmol 36:119–122

    Article  Google Scholar 

  8. Fox RI, Chan R, Michelson JB, Belmont JB, Michelson PE (1984) Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum 27:459–461

    Article  PubMed  CAS  Google Scholar 

  9. Tsubota K, Goto E, Fujita H, Ono M, Inoue H, Saito I, Shimmura S (1999) Treatment of dry eye by autologous serum application in Sjogren's syndrome. Br J Ophthalmol 83:390–395

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  10. Matsumoto Y, Dogru M, Goto E, Ohashi Y, Kojima T, Ishida R, Tsubota K (2004) Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology 111:1115–1120

    Article  PubMed  Google Scholar 

  11. Jeng BH, Dupps WJ Jr (2009) Autologous serum 50 % eyedrops in the treatment of persistent corneal epithelial defects. Cornea 28:1104–1108

    Google Scholar 

  12. del Castillo JM, de la Casa JM, Sardina RC, Fernandez RM, Feijoo JG, Gomez AC, Rodero MM, Sánchez JG (2002) Treatment of recurrent corneal erosions using autologous serum. Cornea 21:781–783

    Article  PubMed  Google Scholar 

  13. Kojima T, Ishida R, Dogru M, Goto E, Matsumoto Y, Kaido M, Tsubota K (2005) The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case–control study. Am J Ophthalmol 139:242–246

    Article  PubMed  Google Scholar 

  14. Tananuvat N, Daniell M, Sullivan LJ, Yi Q, McKelvie P, McCarty DJ, Taylor HR (2001) Controlled study of the use of autologous serum in dry eye patients. Cornea 20:802–806

    Article  PubMed  CAS  Google Scholar 

  15. Mertzanis P, Abetz L, Rajagopalan K, Espindle D, Chalmers R, Snyder C, Caffery B, Edrington T, Simpson T, Nelson JD, Begley C (2005) The relative burden of dry eye in patients' lives: comparisons to a U.S. normative sample. Invest Ophthalmol Vis Sci 46:46–50

    Article  PubMed  Google Scholar 

  16. Bron AJ (1997) The Doyne Lecture. Reflections on the tears. Eye 11:583–602

    Article  PubMed  Google Scholar 

  17. Behrens A, Doyle JJ, Stern L, Chuck RS, McDonnell PJ, Azar DT, Dua HS, Hom M, Karpecki PM, Laibson PR, Lemp MA, Meisler DM, Del Castillo JM, O'Brien TP, Pflugfelder SC, Rolando M, Schein OD, Seitz B, Tseng SC, van Setten G, Wilson SE, Yiu SC, Dysfunctional tear syndrome study group (2006) Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea 25:900–907

    Article  PubMed  Google Scholar 

  18. Bron AJ, Evans VE, Smith JA (2003) Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea 22:640–650

    Article  PubMed  Google Scholar 

  19. Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL (2000) Reliability and validity of the ocular surface disease index. Arch Ophthalmol 118:615–621

    Article  PubMed  CAS  Google Scholar 

  20. Cristhian A, Urzua DHV, Huidobro A, Hernandez H, Alfaro J (2012) Randomized double-blind clinical trial of autologous serum versus artificial tears in dry eye syndrome. Curr Eye Res 37:684–688

    Article  CAS  Google Scholar 

  21. Goto E, Shimmura S, Shimazaki J, Tsubota K (2001) Treatment of superior limbic keratoconjunctivitis by application of autologous serum. Cornea 20:807–810

    Article  PubMed  CAS  Google Scholar 

  22. Tsubota K, Goto E, Shimmura S, Shimazaki J (1999) Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology 106:1984–1989

    Article  PubMed  CAS  Google Scholar 

  23. Ogawa Y, Okamoto S, Mori T, Yamada M, Mashima Y, Watanabe R, Kuwana M, Tsubota K, Ikeda Y, Oguchi Y (2003) Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant 31:579–583

    Article  PubMed  CAS  Google Scholar 

  24. Geerling G, Maclennan S, Hartwig D (2004) Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol 88:1467–1474

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  25. Rocha EM, Pelegrino FS, de Paiva CS, Vigorito AC, de Souza CA (2000) GVHD dry eyes treated with autologous serum tears. Bone Marrow Transplant 25:1101–1103

    Article  PubMed  CAS  Google Scholar 

  26. Kojima T, Higuchi A, Goto E, Matsumoto Y, Dogru M, Tsubota K (2008) Autologous serum eye drops for the treatment of dry eye diseases. Cornea 27:25–30

    Article  Google Scholar 

  27. Cho YK, Huang W, Kim GY, Lim BS (2013) Comparison of autologous serum eye drops with different diluents. Curr Eye Res 38:9–17

    Article  PubMed  CAS  Google Scholar 

  28. Gupta A, Monroy D, Ji Z, Yoshino K, Huang A, Pflugfelder SC (1996) Transforming growth factor beta-1 and beta-2 in human tear fluid. Curr Eye Res 15:605–614

    Article  PubMed  CAS  Google Scholar 

  29. McDonnell PJ, Schanzlin DJ, Rao NA (1988) Immunoglobulin deposition in the cornea after application of autologous serum. Arch Ophthalmol 106:1423–1425

    Article  PubMed  CAS  Google Scholar 

  30. Sosa AB, Epstein SP, Asbell PA (2008) Evaluation of toxicity of commercial ophthalmic fluoroquinolone antibiotics as assessed on immortalized corneal and conjunctival epithelial cells. Cornea 27:930–934

    Article  PubMed  Google Scholar 

  31. Lin CP, Boehnke M (2000) Effect of fortified antibiotic solutions on corneal epithelial wound healing. Cornea 19:204–206

    Article  PubMed  CAS  Google Scholar 

  32. Quinto GG, Campos M, Behrens A (2008) Autologous serum for ocular surface diseases. Arq Bras Oftalmol 71:47–54

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ali Riza Cenk Celebi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Celebi, A.R.C., Ulusoy, C. & Mirza, G.E. The efficacy of autologous serum eye drops for severe dry eye syndrome: a randomized double-blind crossover study. Graefes Arch Clin Exp Ophthalmol 252, 619–626 (2014). https://doi.org/10.1007/s00417-014-2599-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-014-2599-1

Keywords

Navigation